<div id="readability-page-1"><div><p>Health-care companies fell, but not by as much as the broad market, as traders sought out defensive sectors ahead of consumer inflation data.</p><p>    A handful of frustrated House Republicans signed on to a Democratic measure to force a vote on extending enhanced Affordable Care Act subsidies, over the staunch objections of House Speaker Mike Johnson (R., La.). </p><p>    Swiss drug giants Novartis and Roche Holding could soon unveil a drug-price deal with the Trump administration, Bloomberg reported. </p><p>   Write to Rob Curran at rob.curran@dowjones.com </p><p>    (END) Dow Jones Newswires</p><p>12-17-25 1732ET</p></div></div>

<p>Health-care stocks declined less than the broader market as traders favored defensive sectors before inflation data release. Some House Republicans joined Democrats to push for a vote on extending Affordable Care Act subsidies, against Speaker Mike Johnson's objections. Novartis and Roche may announce a drug-price deal with the Trump administration, according to Bloomberg.</p>

Health Care Down, but Not by Much, Amid Defensive Bias -- Health Care Roundup